Maryland 2022 Regular Session

Maryland Senate Bill SB19 Latest Draft

Bill / Chaptered Version Filed 06/07/2022

                             LAWRENCE J. HOGAN, JR., Governor Ch. 720 
 
– 1 – 
Chapter 720 
(Senate Bill 19) 
 
AN ACT concerning 
 
Pharmacists – Administration of Maintenance Injectable Medications – 
Medications for Treatment of Sexually Transmitted Infections 
 
FOR the purpose of altering the definition of “maintenance injectable medication” for the 
purposes of provisions of law governing the administration of maintenance injectable 
medications by pharmacists to include a medication that treats a sexually 
transmitted infection and is not a vaccine defining “injectable medications for 
treatment of sexually transmitted infections” for the purposes of authorizing 
pharmacists to administer the medications; requiring certain insurers, nonprofit 
health service plans, health maintenance organizations, the Maryland Medical 
Assistance Program, and the Maryland Children’s Health Program to provide certain 
coverage for the administration of the medication by a pharmacist; and generally 
relating to the administration of maintenance injectable medications by 
pharmacists. 
 
BY repealing and reenacting, with amendments, 
 Article – Health Occupations 
Section 12–101(o–1) 
 Annotated Code of Maryland 
 (2021 Replacement Volume) 
 
BY repealing and reenacting, with amendments, 
 Article – Health – General 
 Section 15–148(c) 
 Annotated Code of Maryland 
 (2019 Replacement Volume and 2021 Supplement) 
 
BY adding to 
 Article – Health Occupations 
 Section 12–101(l–1) 
 Annotated Code of Maryland 
 (2021 Replacement Volume)  
 
BY repealing and reenacting, without with amendments, 
 Article – Health Occupations 
Section 12–509(a) and (b) 12–509 
 Annotated Code of Maryland 
 (2021 Replacement Volume) 
 
BY repealing and reenacting, with amendments, 
 Article – Insurance  Ch. 720 	2022 LAWS OF MARYLAND  
 
– 2 – 
 Section 15–716 
 Annotated Code of Maryland 
 (2017 Replacement Volume and 2021 Supplement)  
 
 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 
That the Laws of Maryland read as follows: 
 
Article – Health – General 
 
15–148. 
 
 (c) The Program and the Maryland Children’s Health Program shall provide 
coverage for services, to the same extent as services rendered by any other licensed health 
care practitioner, rendered to an enrollee by a licensed pharmacist under: 
 
 (1) § 12–509 of the Health Occupations Article in administering 
self–administered medications [or], maintenance injectable medications, OR INJECTABLE 
MEDICATIONS FOR TREA TMENT OF SEXUALLY TR ANSMITTED INFECTIONS ; or 
 
 (2) § 12–511 of the Health Occupations Article in screening an enrollee and 
prescribing contraceptives for the enrollee.  
 
Article – Health Occupations 
 
12–101. 
 
 (o–1) (1) “Maintenance injectable medication” means a medication that: 
 
 (i) Is administered by injection other than intravenously; and 
 
 (ii) 1. Treats a chronic need, condition, or disorder; OR 
 
 2. TREATS A SEXUALLY TRA NSMITTED INFECTION A ND 
IS NOT A VACCINE . 
 
 (2) “Maintenance injectable medication” includes a medication for the 
treatment of a psychiatric disorder or substance use disorder, contraception, and vitamins. 
 
 (L–1) “INJECTABLE MEDICATION FOR TREATMENT OF A S	EXUALLY 
TRANSMITTED INFECTIO N” MEANS A MEDICATION T HAT: 
 
 (1) IS ADMINISTERED BY IN JECTION OTHER THAN I NTRAVENOUSLY ;  
 
 (2) TREATS A SEXUALLY TRANSMITTED INFECTIO N; AND 
   LAWRENCE J. HOGAN, JR., Governor Ch. 720 
 
– 3 – 
 (3) IS NOT A VACCINE.  
 
12–509. 
 
 (a) In addition to the authority granted to a pharmacist under § 12–508 of this 
subtitle, a pharmacist, in accordance with regulations adopted by the Board, may 
administer: 
 
 (1) A self–administered drug to a patient that is prescribed by an 
authorized prescriber; and 
 
 (2) Subject to subsection (b) of this section, a maintenance injectable 
medication OR AN INJECTABLE MED ICATION FOR TREATMEN T OF A SEXUALLY 
TRANSMITTED INFECTIO N that is not a biological product to a patient: 
 
 (i) That is prescribed by an authorized prescriber; 
 
 (ii) In accordance with a standing order issued by an authorized 
public health official; or 
 
 (iii) In accordance with a protocol under Subtitle 6A of this title. 
 
 (b) A pharmacist may not administer an initial dose of a maintenance injectable 
medication product OR AN INJECTABLE MED ICATION FOR TREATMEN T OF A SEXUALLY 
TRANSMITTED INFECTIO N under subsection (a)(2) of this section unless the pharmacist 
receives written approval from the prescriber. 
 
 (c) (1) On or before September 1, 2021, the Board, in consultation with the 
State Board of Physicians and the State Board of Nursing, shall adopt regulations 
establishing standard procedures: 
 
 (i) For notifying a patient about payment for services before the 
pharmacist administers a maintenance injectable medication OR AN INJECTABLE 
MEDICATION FOR TREAT MENT OF A SEXUALLY T RANSMITTED INFECTION ; 
 
 (ii) That a pharmacist must use to administer [a]: 
 
 1. A maintenance injectable medication after an initial dose 
is administered by the prescriber; OR 
 
 2. AN INJECTABLE MEDICAT ION FOR TREATMENT OF A 
SEXUALLY TRANSMITTED INFECTION; 
 
 (iii) That a pharmacist must use to administer an initial dose of a 
maintenance injectable medication OR AN INJECTABLE MED ICATION FOR TREATMEN T  Ch. 720 	2022 LAWS OF MARYLAND  
 
– 4 – 
OF A SEXUALLY TRANSM ITTED INFECTION if the administration of the initial dose is 
authorized under subsection (b) of this section; and 
 
 (iv) For communicating to the prescriber whether a medication was 
administered to a specific patient and relevant information about the patient’s condition. 
 
 (2) The regulations shall require a pharmacist to: 
 
 (i) Except as provided in paragraph (3) of this subsection, complete 
a training program approved by the Board for: 
 
 1. Administering maintenance injectable medications AND 
INJECTABLE MEDICATIO NS FOR TREATMENT OF A SEXUALLY TRANSMITT ED 
INFECTION; and 
 
 2. Managing the populations the pharmacist serves, the 
medications being administered, and the current guidelines relating to these populations 
and medications; 
 
 (ii) Follow the standard procedures established by the Board; and 
 
 (iii) After administering a maintenance injectable medication OR AN 
INJECTABLE MEDICATIO N FOR TREA TMENT OF A SEXUALLY TRANSMITTED 
INFECTION: 
 
 1. Notify the prescriber that the maintenance injectable 
medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A SEXUALLY 
TRANSMITTED INFECTIO N was administered and of any relevant details about the 
patient’s condition; 
 
 2. Provide the patient with a written record of the 
maintenance injectable medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A 
SEXUALLY TRANSMITTED INFECTION administered; 
 
 3. Record in any electronic or written health record on the 
patient maintained by the pharmacist: 
 
 A. The administering of the maintenance injectable 
medication OR INJECTABLE MEDICA TION FOR TREATMENT O F A SEXUALLY 
TRANSMITTED INFECTIO N; and 
 
 B. Any pertinent details about the patient’s condition; and 
 
 4. Notify the patient of the need to attend any upcoming 
appointments the patient has scheduled with the prescriber.   LAWRENCE J. HOGAN, JR., Governor Ch. 720 
 
– 5 – 
 
 (3) The regulations shall waive the requirement to complete a training 
program for a pharmacist who already has undergone the training as part of the 
pharmacist’s formal educational program. 
 
Article – Insurance 
 
15–716. 
 
 (a) This section applies to individual, group, or blanket health insurance policies 
and contracts delivered or issued for delivery in the State by insurers, nonprofit health 
service plans, and health maintenance organizations that provide coverage for patient 
assessment regarding, and administration of, self–administered medications [and], 
maintenance injectable medications, AND INJECTABLE MEDIC ATIONS FOR TREATMENT 
OF SEXUALLY TRANSMIT TED INFECTIONS . 
 
 (b) An entity subject to this section shall provide coverage for services rendered by 
a licensed pharmacist under § 12–509 of the Health Occupations Article to an individual 
who is covered under a policy or contract issued or delivered by the entity, to the same extent 
as services rendered by any other licensed health care practitioner, for patient assessment 
regarding and in administering self–administered medications [or], maintenance injectable 
medications, OR INJECTABLE MEDICA TIONS FOR TREATMENT OF SEXUALLY 
TRANSMITTED INFECTIO NS. 
 
 SECTION 2. AND BE IT FURTHER ENACTED, That, to the extent determined 
appropriate by the State Board of Pharmacy, the regulations adopted by the State Board of 
Pharmacy, in consultation with the State Board of Physicians and the State Board of 
Nursing, under § 12–509 of the Health Occupations Article, as enacted by Chapters 757 and 
758 of the Acts of the General Assembly of 2021, for the administration of maintenance 
injectable medications by a pharmacist shall be the same regulations for the administration 
of injectable medications for treatment of sexually transmitted infections by a pharmacist 
adopted in accordance with § 12–509 of the Health Occupations Article, as enacted by this 
Act.  
 
 SECTION 2. 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 
October 1, 2022. 
 
Enacted under Article II, § 17(c) of the Maryland Constitution, May 29, 2022.